Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises.
Anestopoulos I, Kyriakou S, Tragkola V, Paraskevaidis I, Tzika E, Mitsiogianni M, Deligiorgi MV, Petrakis G, Trafalis DT, Botaitis S, Giatromanolaki A, Koukourakis MI, Franco R, Pappa A, Panayiotidis MI.
Anestopoulos I, et al. Among authors: panayiotidis mi.
Pharmacol Ther. 2022 Dec;240:108301. doi: 10.1016/j.pharmthera.2022.108301. Epub 2022 Oct 23.
Pharmacol Ther. 2022.
PMID: 36283453
Review.